Dipyridamole myocardial perfusion imaging for coronary heart disease

K. A. Eagle; H. W. Strauss; C. A. Boucher

Dipyridamole myocardial perfusion imaging for coronary heart disease

K. A. Eagle
, H. W. Strauss
, C. A. Boucher

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Dipyridamole thallium imaging has been proven to be a useful noninvasive test for the evaluation of patients with suspected coronary artery disease. In this report, we discuss the mechanism of dipyridamole's effect on coronary flow, review protocols for performing the test, and discuss the effects of dipyridamole on vital signs, the electrocardiogram, and patients' symptoms. Furthermore, we summarize the present understanding of the indications, sensitivity, specificity, and limitations of this modality.

Original language	English
Pages (from-to)	292-303
Number of pages	12
Journal	American Journal of Cardiac Imaging
Volume	2
Issue number	4
State	Published - 1988
Externally published	Yes

Cite this

@article{72b94f4f56964dfca3eea0e456321060,

title = "Dipyridamole myocardial perfusion imaging for coronary heart disease",

abstract = "Dipyridamole thallium imaging has been proven to be a useful noninvasive test for the evaluation of patients with suspected coronary artery disease. In this report, we discuss the mechanism of dipyridamole's effect on coronary flow, review protocols for performing the test, and discuss the effects of dipyridamole on vital signs, the electrocardiogram, and patients' symptoms. Furthermore, we summarize the present understanding of the indications, sensitivity, specificity, and limitations of this modality.",

author = "Eagle, \{K. A.\} and Strauss, \{H. W.\} and Boucher, \{C. A.\}",

year = "1988",

language = "English",

volume = "2",

pages = "292--303",

journal = "American Journal of Cardiac Imaging",

issn = "0887-7971",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Dipyridamole myocardial perfusion imaging for coronary heart disease

AU - Eagle, K. A.

AU - Strauss, H. W.

AU - Boucher, C. A.

PY - 1988

Y1 - 1988

N2 - Dipyridamole thallium imaging has been proven to be a useful noninvasive test for the evaluation of patients with suspected coronary artery disease. In this report, we discuss the mechanism of dipyridamole's effect on coronary flow, review protocols for performing the test, and discuss the effects of dipyridamole on vital signs, the electrocardiogram, and patients' symptoms. Furthermore, we summarize the present understanding of the indications, sensitivity, specificity, and limitations of this modality.

AB - Dipyridamole thallium imaging has been proven to be a useful noninvasive test for the evaluation of patients with suspected coronary artery disease. In this report, we discuss the mechanism of dipyridamole's effect on coronary flow, review protocols for performing the test, and discuss the effects of dipyridamole on vital signs, the electrocardiogram, and patients' symptoms. Furthermore, we summarize the present understanding of the indications, sensitivity, specificity, and limitations of this modality.

UR - https://www.scopus.com/pages/publications/0024209428

M3 - Article

AN - SCOPUS:0024209428

SN - 0887-7971

VL - 2

SP - 292

EP - 303

JO - American Journal of Cardiac Imaging

JF - American Journal of Cardiac Imaging

IS - 4

ER -

Dipyridamole myocardial perfusion imaging for coronary heart disease

Abstract

Fingerprint

Cite this